
Jessica Perego, PhD
Founder, CEO & Lead Scientist
Microbiome science and neuroactive metabolites, connecting biological research with clinical questions.
OUR STORY & SCIENCE
Neurabi began with a question: could a better understanding of the gut microbiome help us look at neurological care differently?
In development · Pilot study in preparationWe bring together microbiome science, business development and artificial intelligence. Our work is at an early stage, and we investigate carefully before we claim anything.

Founder, CEO & Lead Scientist
Microbiome science and neuroactive metabolites, connecting biological research with clinical questions.
Co-CEO
Business development, financial structuring, partnerships and a sustainable path from research to practice.

AI/ML Developer
In-house machine learning, data engineering, model evaluation and understandable research tools.
OUR JOURNEY
Four milestones, from the prototype that exists today to a service that would follow validation. Timing depends on research findings, partnerships and the necessary approvals.
The research method, the portal and clinician review have been built and tested with example data.
Agreeing the study protocol, laboratory arrangements and clinical input, and preparing for the required approvals.
Run the pilot once approved, with follow-up and repeat samples, to find out whether this is feasible and useful.
Further validation and any regulatory steps would come before a service could become available.
THE SCIENCE, SIMPLY
Your gut does more than digest food. It is part of a network of signals that connects with your brain. Researchers call this the gut–brain axis.
Explore the three pathways
Nerves, including the vagus nerve, carry messages between the gut and the brain. Communication travels in both directions.
The gut, its microorganisms and the immune system interact. Scientists are studying how these signals relate to processes in the brain.
Gut microorganisms help break down food and produce molecules called metabolites. Researchers are exploring how these molecules interact with the body and brain.
Understanding a connection is where research begins. Neurabi is a research project, and nothing on this website is a way to prevent, diagnose or treat a condition.
Explore the scienceTHE SCIENCE, SIMPLY
A growing field of research, with important unanswered questions. These publications are the background to our question. Neurabi’s own evidence has still to come from its studies.
REVIEW · 2024
A review of communication pathways and preclinical and clinical research. It highlights a field to investigate, not a proven Neurabi intervention.
Read the publicationOBSERVATIONAL RESEARCH · 2022
Research into associations between the microbiome and multiple sclerosis. An association alone does not establish causation or clinical usefulness.
Read the publicationTHE NEXT CHAPTER STARTS WITH A QUESTION.
A clinician, a researcher, a patient organisation, or simply curious? We’d like to hear from you.
Get in touchNeurabi is developing AI-powered, personalised microbiome-based approaches for neurological and neuropsychiatric disorders, with an initial focus on multiple sclerosis, Parkinson’s disease and Alzheimer’s disease.
Support the clinical development of our AI-powered platform for microbiome-informed precision medicine.
Scientific collaboration and co-authorship opportunities.